EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹8,122 Cr | ₹7,709 Cr | ₹6,573 Cr | ₹5,947 Cr | ₹6,659 Cr |
What is the latest Total Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹8,122 Cr |
| Mar2024 | ₹7,709 Cr |
| Mar2023 | ₹6,573 Cr |
| Mar2022 | ₹5,947 Cr |
| Mar2021 | ₹6,659 Cr |
How is Total Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹8,122 Cr | 5.35 | |
| Mar2024 | ₹7,709 Cr | 17.28 | |
| Mar2023 | ₹6,573 Cr | 10.53 | |
| Mar2022 | ₹5,947 Cr | -10.69 | |
| Mar2021 | ₹6,659 Cr | - | |
Compare Total Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹29,153.8 Cr | 3.3% | 11.2% | 15.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -3.6% | -6.8% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -5.4% | -2.4% | 3.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 3.6% | 8.5% | 23.5% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -5.1% | -7.1% | -3.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -4.1% | -8.3% | -12.1% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 3.3% |
11.2% |
15.4% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses